InhaleRx Appoints Darryl Davies as CEO
- Healthcare and technology company InhaleRx (IRX) appoints Darryl Davies as CEO, effective immediately
- Mr Davies joined the company’s board in July 2021 and has over 16 years of experience in psychology, harm minimisation and healthcare commercialisation
- He launched Australia’s first university-partnered educational programs for the cannabis industry and has coordinated doctor education initiative across Australia
- Further, Dr Rob Jenny has been appointed Chief Scientific Officer while Dr John Crock has been appointed Non-Executive Director
- The company is up 6.67 per cent on the market with shares trading at 6.4 cents at 1:53 pm AEST
